MUNICH, Germany, March 31 /PRNewswire-FirstCall/ -- Thermo Fisher Scientific Inc. , the world leader in serving science, today launched a number of innovative new products at Analytica 2008, the world’s largest laboratory technology tradeshow, taking place in Munich, Germany, from April 1 - 4. The company’s new technologies are focused on enabling customers to take advantage of the most advanced solutions available for their application -- from complex research to routine analysis.
“Today, we are unveiling in Europe novel tools that are built upon decades of experience in working with our customers to move science forward,” said Marc N. Casper, executive vice president of Thermo Fisher Scientific. “We’re excited to showcase breakthroughs covering a range of technology platforms, from RNA-interference to elemental analysis, molecular spectroscopy and mass spectrometry. You will also see how our technologies fit together to form a complete workflow, with a comprehensive protein research laboratory replicated in our booth.
“Furthermore, we continue to make strategic acquisitions that complement our technology breadth and strengthen our geographic market position. For example, our additions of NanoDrop micro UV-Vis systems, as well as Flux and La-Pha-Pack chromatography products and consumables, will allow us to more effectively deliver our unmatched offerings to customers in Europe and around the world.”
The industry-leading portfolio of laboratory offerings from the company’s premier brands, Thermo Scientific and Fisher Scientific, is on display in booths 105/204 and 121/220 in Hall B1. Among the new technologies, products and capabilities introduced this year are:
For full press releases announcing all new products at Analytica 2008, please visit the online media room at http://www.thermofisher.com/analytica08.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. With annual revenues of $10 billion, we have more than 30,000 employees and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, we help solve analytical challenges from routine testing to complex research and discovery. Thermo Scientific offers customers a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, we offer the most convenient purchasing options to customers and continuously advance our technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike. Visit http://www.thermofisher.com.
The following constitutes a “Safe Harbor” statement under the Private Securities Litigation Reform Act of 1995: This press release contains forward- looking statements that involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in the company’s Annual Report on Form 10-K for the year ended December 31, 2007, under the caption “Risk Factors,” which is on file with the Securities and Exchange Commission (SEC) and available in the “Investors” section of our Website under the heading “SEC Filings.” We also may make forward-looking statements about the benefits of the merger of Thermo Electron and Fisher Scientific, including statements about future financial and operating results, the new company’s plans, objectives, expectations and intentions and other statements that are not historical facts. Important factors that could cause actual results to differ materially from those indicated by forward-looking statements include risks and uncertainties relating to: the risk that the businesses will not be integrated successfully; the risk that the cost savings and any other synergies from the transaction may not be fully realized or may take longer to realize than expected; disruption from the transaction making it more difficult to maintain relationships with customers, employees or suppliers; competition and its effect on pricing, spending, third-party relationships and revenues; the need to develop new products and adapt to significant technological change; implementation of strategies for improving internal growth; use and protection of intellectual property; dependence on customers’ capital spending policies and government funding policies; realization of potential future savings from new productivity initiatives; general worldwide economic conditions and related uncertainties; the effect of changes in governmental regulations; the effect of exchange rate fluctuations on international operations; the effect of laws and regulations governing government contracts; the effect of competing with certain of our customers and suppliers; and the effect of rapid changes in the healthcare industry. While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, even if our estimates change and, therefore, you should not rely on these forward-looking statements as representing our views as of any date subsequent to today.
lori.gorski@thermofisher.comwww.thermofisher.comken.apicerno@thermofisher.com
CONTACT: Media, Lori Gorski, +1-781-622-1242,
lori.gorski@thermofisher.com, or Investors, Ken Apicerno, +1-781-622-1111,
ken.apicerno@thermofisher.com, both of Thermo Fisher Scientific Inc.
Web site: http://www.thermofisher.com/
Company News On-Call: http://www.prnewswire.com/comp/877850.html/
